PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

ErbB2 blockade with Herceptin (trastuzumab) enhances peripheral nerve regeneration after repair of acute or chronic peripheral nerve injury.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27159537 ↗2016Reported benefit

ErbB2 blockade with Herceptin (trastuzumab) enhances peripheral nerve regeneration after repair of acute or chronic peripheral nerve injury.

RatOtherSprague-DawleyMaleAdministered after nerve transection and repair

Model: Common peroneal nerve transection with immediate repair or repair after 4 months of chronic denervation

Trastuzumab increased the rate of motor and sensory neuron regeneration, Schwann cell proliferation in the distal stump, and the number of myelinated axons regenerating after both immediate and delayed repair.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.